Efficacy of depatuxizumab mafodotin (ABT-414) monotherapy in patients with EGFR-amplified, recurrent glioblastoma: results from a multi-center, international study

Martin van den Bent, HK Gan, AB Lassman, P Kumthekar, R Merrell, N Butowski, Z Lwin, T Mikkelsen, LB Nabors, KP Papadopoulos, M Penas-Prado, J Simes, H Wheeler, T Walbert, AM Scott, E Gomez, H J Lee, L Roberts-Rapp, H (Hong) Xiong, E BainPJ Ansell, KD Holen, D Maag, DA Reardon

Research output: Contribution to journalArticleAcademicpeer-review

102 Citations (Scopus)
13 Downloads (Pure)
Original languageUndefined/Unknown
Pages (from-to)1209-1217
Number of pages9
JournalCancer Chemotherapy & Pharmacology
Issue number6
Publication statusPublished - 2017

Research programs

  • EMC OR-01

Cite this